Balance Labs (NASDAQ: BLNC) notifies SEC of delayed FY2025 10-K filing

Rhea-AI Filing Summary

Balance Labs, Inc. notified the SEC that it cannot timely file its Annual Report on Form 10-K for the period ended December 31, 2025 due to time constraints in compiling and reviewing required financial information. The company states it expects to file the Form 10-K no later than the fifteenth calendar day following the prescribed due date, pursuant to Rule 12b-25.

Key Figures

Period Ended: December 31, 2025 Expected Filing Window: 15 calendar days Contact Phone: (305) 907-7600 +1 more

4 metrics

Period Ended December 31, 2025 Fiscal period covered by the delayed Form 10-K

Expected Filing Window 15 calendar days Extension permitted by Rule 12b-25

Contact Phone (305) 907-7600 Contact for notification: Alan Campbell

Signature Date April 2, 2026 Date the notification was signed by CEO Alan Campbell

Key Terms

Rule 12b-25, Form 10-K, prescribed due date

3 terms

Rule 12b-25 regulatory

"expects to file the Form 10-K no later than the fifteenth calendar day following the prescribed due date"

Rule 12b-25 is an SEC filing provision that lets a company notify regulators and the public that it cannot file a required periodic report (like a quarterly or annual report) on time and explains the reason for the delay. For investors, the notice is a formal heads-up that financial information will arrive late—similar to a company calling to say it will be late turning in homework—so it signals increased uncertainty and may affect trading and risk assessments until the filing is available.

Form 10-K regulatory

"unable to file its Annual Report on Form 10-K for the period ended December 31, 2025"

A Form 10-K is a comprehensive report that publicly traded companies are required to file annually with regulators. It provides a detailed overview of a company's financial health, operations, and risks, similar to a detailed health report. Investors use this information to assess the company's performance and make informed decisions about buying or selling its stock.

prescribed due date regulatory

"file the Form 10-K no later than the fifteenth calendar day following the prescribed due date"

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 12b-25

NOTIFICATION OF LATE FILING

(Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR

For Period Ended: December 31, 2025

Transition Report on Form 10-K ☐

Transition Report on Form 20-F ☐

Transition Report on Form 11-K ☐

Transition Report on Form 10-Q ☐

Transition Report on Form N-SAR ☐

For the Transition Period Ended: _______________________________________________________

Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

PART I — REGISTRANT INFORMATION

Balance Labs, Inc.

Full Name of Registrant

None

Former Name if Applicable

407 Lincoln Road, Suite 701

Address of Principal Executive Office (Street and Number)

Miami Beach, FL 33139

City, State and Zip Code

PART II — RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

	(a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
☒	(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
	(c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III — NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.

Balance Labs, Inc. (the “Company”) is unable to file its Annual Report on Form 10-K (the “Form 10-K”) for the period ended December 31, 2025, within the prescribed period. The compilation, dissemination and review of the financial information required to be presented in the Form 10-K has imposed time constraints on the Company’s management and auditor that have rendered timely filing of the Form 10-K impractical without undue hardship and expense to the Company. At this time, the Company expects to file the Form 10-K no later than the fifteenth calendar day following the prescribed due date, as permitted by Rule 12b-25.

PART IV — OTHER INFORMATION

(1) Name and telephone number of person to contact in regard to this notification

Alan Campbell		305		907-7600
(Name)		(Area Code)		(Telephone Number)

(2) Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed ? If answer is no, identify report(s). Yes ☒ No ☐

(3) Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

Yes ☐ No ☒

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

BALANCE LABS, INC

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

	BALANCE LABS, INC.
Date: April 2, 2026	By:	/s/ Alan Campbell
		Alan Campbell
		Chief Executive Officer (Principal Executive Officer)

FAQ

Why did Balance Labs (BLNC) file a Form 12b-25 for the 2025 10-K?

Balance Labs cited time constraints in compiling, disseminating, and reviewing required financial information. The company said these constraints made timely filing impractical and would impose undue hardship and expense.

When does BLNC expect to file its Form 10-K for the period ended December 31, 2025?

The company expects to file the Form 10-K no later than the fifteenth calendar day following the prescribed due date, relying on the relief provided by SEC Rule 12b-25.

Does the Form 12b-25 state whether Balance Labs anticipates changes in results of operations?

The notification includes a question about anticipated significant changes, but the provided excerpt does not state that any significant change in results of operations is expected to be reflected in the report.

Who can be contacted about BLNC's late filing and what is the contact?

The contact listed is Alan Campbell, reachable at the phone number (305) 907-7600. He is identified as the person to contact regarding the notification.

What relief does Rule 12b-25 provide for BLNC's late 10-K filing?

Rule 12b-25 permits a registrant to notify the SEC and state an expectation to file within specified extra days; Balance Labs invoked the rule and intends to file within the allowed fifteen-calendar-day extension.